Ian Mortimer
Chief Executive Officer bij XENON PHARMACEUTICALS INC.
Vermogen: 2 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Ian Mortimer
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 31 | |
Public Company | Pharmaceuticals: Major | 25 | |
Public Company | Medical Specialties | 22 | |
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ian Mortimer via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | President Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member | |
Merrill Lynch Canada, Inc.
Merrill Lynch Canada, Inc. Investment Banks/BrokersFinance Merrill Lynch Canada, Inc. is a Canadian broker/dealer headquartered in Toronto, Ontario. They are a subsidiary of Midland Walwyn, Inc. and their ultimate parent is Bank of America Corp. (NYSE: BAC). The firm offers brokerage and investment banking services as well as commercial lending, global high-yield debt, global equity, and M&A services to institutional and retail clients. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Director/Board Member Public Communications Contact | |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
ZYNERBA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Consultant / Advisor | |
EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Doctorate Degree | |
GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor | |
McGill University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Masters Business Admin Doctorate Degree | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
University of British Columbia | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Masters Business Admin | |
Simon Fraser University | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
University of Toronto | College/University | Graduate Degree Graduate Degree | |
University of Western Ontario | College/University | Masters Business Admin Graduate Degree | |
University of Victoria | College/University | Graduate Degree Masters Business Admin | |
University of Cape Town | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Association of Corporate Counsel
Association of Corporate Counsel Miscellaneous Commercial ServicesCommercial Services The Association of Corporate Counsel is a bar association that promotes the common professional and business interests of in-house counsel through information, education, networking, and advocacy. The non-profit company is based in Washington and has subsidiaries in the United States. Joining ACC provides access to valuable, supportive resources for every stage of your career. Veta T. Richardson has been the CEO of the American company since 2011. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman Director/Board Member Chairman Corporate Officer/Principal Director/Board Member Director/Board Member | |
ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Law Society of British Columbia
Law Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Law Society of British Columbia provides legal services. The firm protects the public interest in the administration of justice by setting and enforcing standards of professional conduct for lawyers. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Genome British Columbia
Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Michael Smith Foundation for Health Research
Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Eutropics Pharmaceuticals, Inc.
Eutropics Pharmaceuticals, Inc. Internet Software/ServicesTechnology Services Eutropics Pharmaceuticals, Inc. operates as a biomarker technology platform for accelerating drug discovery and development. The private company is based in Cambridge, MA. The company was founded in 2005 by Gary E. Frashier, Michael Cardone. Michael Cardone has been the CEO since 2005. | Internet Software/Services | Founder Chief Operating Officer | |
Allergen NCE, Inc.
Allergen NCE, Inc. Miscellaneous Commercial ServicesCommercial Services Allergen NCE, Inc.is a national research network, seeking asthma and allergy treatment from a naturopath. It invests in training the next generation of researchers, innovators and clinician-scientists. The company was founded in 2004 and is headquartered in Hamilton, Canada. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Biotechnology | Chairman Director/Board Member | |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Public Communications Contact Chairman Human Resources Officer | |
AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Director/Board Member | |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The private company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistieken
Internationaal
Canada | 35 |
Verenigde Staten | 13 |
Israël | 2 |
Verenigd Koninkrijk | 2 |
Frankrijk | 2 |
Sectoraal
Health Technology | 28 |
Consumer Services | 11 |
Commercial Services | 8 |
Finance | 4 |
Health Services | 2 |
Operationeel
Director/Board Member | 347 |
Corporate Officer/Principal | 155 |
Independent Dir/Board Member | 92 |
Chairman | 80 |
President | 75 |
Sterkste connecties
Insiders | |
---|---|
Ken Galbraith | 30 |
Clarence Machado | 29 |
Dan Kisner | 29 |
Frank Holler | 29 |
Darrell J. Elliott | 29 |
Michael Hayden | 27 |
Richard Scheller | 27 |
R. MacKay-Dunn | 26 |
Gary E. Frashier | 26 |
Aaron Davidson | 24 |
Ronald Ian Lennox | 22 |
Simon Pimstone | 22 |
Suzanne Foster | 22 |
Mohammad Azab | 21 |
Tony Holler | 19 |
- Beurs
- Insiders
- Ian Mortimer
- Bedrijfsconnecties